> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hahn Briefs House Committee on Covid-19 Efforts
- URL: https://www.fdaweb.com/hahn-briefs-house-committee-on-covid-19-efforts/
- Published: 2020-04-22T12:00:00.000Z
- Updated: 2026-09-14T16:12:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146632

FDA commissioner **Stephen Hahn** 4/22 provided a teleconference briefing to House Energy and Commerce Committee members on the agency’s response to the coronavirus pandemic. “Today’s conversation helps us continue our oversight responsibilities and will inform our ongoing work to address this terrible pandemic,” committee leaders said in a [statement ](https://energycommerce.house.gov/newsroom/press-releases/ec-committee-members-hold-bipartisan-teleconference-with-fda-commissioner?ref=fdaweb.com)after the call.

According to the statement, the bipartisan members discussed a number of issues with Hahn, including:

- An update on FDA’s efforts to support Covid-19 vaccine, therapeutics and serological test development;
- FDA’s ongoing work with test developers, laboratories and other federal agencies to validate serological tests;
- Actions FDA will take to help states acquire the necessary supplies to expand testing capacity;
- FDA’s commitment to upholding the agency’s medical product “gold standard” for safety and effectiveness for all medical products to treat Covid-19 and guarantee that science and data lead those decisions; and
- The role advanced manufacturing might play moving forward to increase domestic manufacturing, guarantee quality and reduce treatment shortages.